Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.298 SEK | -0.67% | +4.20% | +9.96% |
05-24 | Xintela AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-23 | Xintela and EQGen Biomedical to Collaborate to Develop EQSTEM Stem Cell Treatment for Horses | CI |
Chart: Technical Analysis
- Stock Market
- Equities
- XINT Stock
- Charts Xintela AB